The diffusion of minimally invasive surgery has thrived in recent years, providing substantial benefits over traditional techniques for a number of surgical interventions. This rapid growth has been possible due to significant advancements in medical technology, which partly solved some of the technical and clinical challenges associated with minimally invasive techniques. The issues that still limit its widespread adoption for some applications include the limited field of view; reduced manoeuvrability of the tools; lack of haptic feedback; loss of depth perception; extended learning curve; prolonged operative times and higher financial costs. The present review discusses some of the main recent technological advancements that fuelled the uptake of minimally invasive surgery, focussing especially on the areas of imaging, instrumentation, cameras and robotics. The current limitations of state-of-the-art technology are identified and addressed, proposing future research directions necessary to overcome them
Background The Coronavirus disease 2019 (COVID-19) pandemic has underlined the urgent need for reliable, multicenter, and full-admission intensive care data to advance our understanding of the course of the disease and investigate potential treatment strategies. In this study, we present the Dutch Data Warehouse (DDW), the first multicenter electronic health record (EHR) database with full-admission data from critically ill COVID-19 patients. Methods A nation-wide data sharing collaboration was launched at the beginning of the pandemic in March 2020. All hospitals in the Netherlands were asked to participate and share pseudonymized EHR data from adult critically ill COVID-19 patients. Data included patient demographics, clinical observations, administered medication, laboratory determinations, and data from vital sign monitors and life support devices. Data sharing agreements were signed with participating hospitals before any data transfers took place. Data were extracted from the local EHRs with prespecified queries and combined into a staging dataset through an extract–transform–load (ETL) pipeline. In the consecutive processing pipeline, data were mapped to a common concept vocabulary and enriched with derived concepts. Data validation was a continuous process throughout the project. All participating hospitals have access to the DDW. Within legal and ethical boundaries, data are available to clinicians and researchers. Results Out of the 81 intensive care units in the Netherlands, 66 participated in the collaboration, 47 have signed the data sharing agreement, and 35 have shared their data. Data from 25 hospitals have passed through the ETL and processing pipeline. Currently, 3464 patients are included in the DDW, both from wave 1 and wave 2 in the Netherlands. More than 200 million clinical data points are available. Overall ICU mortality was 24.4%. Respiratory and hemodynamic parameters were most frequently measured throughout a patient's stay. For each patient, all administered medication and their daily fluid balance were available. Missing data are reported for each descriptive. Conclusions In this study, we show that EHR data from critically ill COVID-19 patients may be lawfully collected and can be combined into a data warehouse. These initiatives are indispensable to advance medical data science in the field of intensive care medicine.
Objectives: Unexpected ICU readmission is associated with longer length of stay and increased mortality. To prevent ICU readmission and death after ICU discharge, our team of intensivists and data scientists aimed to use AmsterdamUMCdb to develop an explainable machine learning–based real-time bedside decision support tool. Derivation Cohort: Data from patients admitted to a mixed surgical-medical academic medical center ICU from 2004 to 2016. Validation Cohort: Data from 2016 to 2019 from the same center. Prediction Model: Patient characteristics, clinical observations, physiologic measurements, laboratory studies, and treatment data were considered as model features. Different supervised learning algorithms were trained to predict ICU readmission and/or death, both within 7 days from ICU discharge, using 10-fold cross-validation. Feature importance was determined using SHapley Additive exPlanations, and readmission probability-time curves were constructed to identify subgroups. Explainability was established by presenting individualized risk trends and feature importance. Results: Our final derivation dataset included 14,105 admissions. The combined readmission/mortality rate within 7 days of ICU discharge was 5.3%. Using Gradient Boosting, the model achieved an area under the receiver operating characteristic curve of 0.78 (95% CI, 0.75–0.81) and an area under the precision-recall curve of 0.19 on the validation cohort ( n = 3,929). The most predictive features included common physiologic parameters but also less apparent variables like nutritional support. At a 6% risk threshold, the model showed a sensitivity (recall) of 0.72, specificity of 0.70, and a positive predictive value (precision) of 0.15. Impact analysis using probability-time curves and the 6% risk threshold identified specific patient groups at risk and the potential of a change in discharge management to reduce relative risk by 14%. Conclusions: We developed an explainable machine learning model that may aid in identifying patients at high risk for readmission and mortality after ICU discharge using the first freely available European critical care database, AmsterdamUMCdb. Impact analysis showed that a relative risk reduction of 14% could be achievable, which might have significant impact on patients and society. ICU data sharing facilitates collaboration between intensivists and data scientists to accelerate model development.
Through deep learning and computer vision techniques, driving manoeuvres can be predicted accurately a few seconds in advance. Even though adapting a learned model to new drivers and different vehicles is key for robust driverassistance systems, this problem has received little attention so far. This work proposes to tackle this challenge through domain adaptation, a technique closely related to transfer learning. A proof of concept for the application of a Domain-Adversarial Recurrent Neural Network (DA-RNN) to multi-modal time series driving data is presented, in which domain-invariant features are learned by maximizing the loss of an auxiliary domain classifier. Our implementation is evaluated using a leave-one-driver-out approach on individual drivers from the Brain4Cars dataset, as well as using a new dataset acquired through driving simulations, yielding an average increase in performance of 30% and 114% respectively compared to no adaptation. We also show the importance of finetuning sections of the network to optimise the extraction of domain-independent features. The results demonstrate the applicability of the approach to driverassistance systems as well as training and simulation environments.Experiment 3 Finally, we implement the same domain-adversarial approach to study how the network, trained only on the Brain4Cars data, adapts to our new dataset, in which the drivers and the driving set-up -e.g. position of the mirrors, windows, and the camera-differ from the Brain4Cars dataset.The results confirm that, without adaptation, the model is not able to predict manoeuvres from observations in which the features have very different marginal distributions compared to the training set. We conclude discussing the potential applications of the domain-adversarial approach to apply domain 4
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.